Leadership

Executive Director & Chairman of the Board, ARMI

Deputy Executive Director & Secretary of the Board

Chief Technology Officer


Ph.D., M.D., Chief Regulatory Officer, BioFabUSA

Chief Operating Officer, BioFabUSA

Chief Strategy Officer, BioFabUSA

Chief Innovation Officer, BioFabUSA

Chief Workforce Officer, BioFabUSA

Chief Operating Officer, ARMI

Chief Development Officer, ARMI

Chief Education & Workforce Officer, ARMI
Board of Directors
Like-minded people—who are from different spheres but have changed the world in their own ways—make up ARMI’s board of directors.

ARMI Executive Director, DEKA CEO, serial inventor and FIRST founder

United Therapeutics CEO and Sirius Satellite Radio founder

Boston Scientific founder and medical device pioneer

Senior Vice President for Microsoft Healthcare, and former CEO of Dartmouth-Hitchcock

Worcester Polytechnic Institute President

Rockwell Automation CEO and veterans and workforce-development champion
Stakeholder Council
The Stakeholder Council is a combination of ARMI’s board of directors and highly relevant leadership at the U.S. Department of Defense.
Dean Kamen, DEKA Research and Development
Martine Rothblatt, United Therapeutics
John Abele, Boston Scientific
Lt. Col. Eaton, U.S. Army
Dr. Lloyd Rose, USAMMDA
Dawn Rosarius, MRDC
Jim Weinstein, Microsoft
Laurie Leshin, Worcester Polytechnic Institute
Blake Moret, Rockwell Automation
Tracy Frost, U.S. Department of Defense
Dr. Michelle Rozo, U.S. Department of Defense

Leadership Advisory Council
The Leadership Advisory Council (LAC) provides industry expertise and strategic guidance to the stakeholder council. Members of the council are elected by BioFabUSA’s membership. The Technical Advisory Subcommittee (TASC) works to organize and provide technical input from BioFabUSA members. This group comprised of six individuals from the LAC.
Amy Peterson, University of Massachusetts, Lowell
Andrew Lee, Fluidform
Anna Gosiewska, Celularity
Caralynn Nowinski Collens, Dimension Inx
Carina Clingman, Recruitomics
Cato Laurencin, University of Connecticut
Dave Lewandowski, Azenta Life Sciences
Eric Schuur, HepaTx
Esther Latres, Juvenile Diabetes Research Foundation
Gagan Naeger, Rockwell Automation
George Christ, University of Virginia
George Pins, Worcester Polytechnic Institute
Jan Jensen, Trailhead Bio
Jian Ling, Southwest Research Institute
Katie Zander, Standards Coordinating Body, TASC
Lisa Larkin, Skeletal Tissue Engineering Laboratory
Marcie Black, Advanced Silicon Group
Maria Pascale, MPR Associates
Marian McCord, University of New Hampshire
Mark Powers, ThermoFisher Scientific
Michael Golway, Advanced Solutions Life Sciences, TASC
Orchid Garcia, J&J, TASC
Paul Goodwin, Cytiva
Priya Baraniak, OrganaBio, TASC
Sarindr “Ik” Bhumiratana, Epibone
Shivaram Selvam, Georgia Tech, TASC
Stu Jacobson, DEKA, TASC
Tim Bertram, ProKidney
